Our funding programs support early stage, Ohio-based companies to achieve success.

Cell Targeting, Inc.

Cell Targeting, Inc. is a preclinical-stage company developing a drug delivery platform utilizing a tissue-specific peptide targeting technology with broad therapeutic potential, including delivery of cardiovascular cellular therapies. In January 2011 the company technology was acquired by BioTime, Inc.

view all portfolio clients